We are international
Donate
TEXT SIZE   
back

Myeloma Minute
March 20, 2014
03.20.14

March 20, 2014

Share the Minute

Facebook

Tweet!

Clinical Trials

Donate to the IMF

 


In case you missed it...



Listen to Archived
IMF Teleconference:
"Chemo Brain – Is It Real?"


UPCOMING EVENTS



Saturday, April 26, 2014
Regional Community Workshop
Virginia Beach, Virginia


z

Friday, May 16, 2014
Patient & Family Seminar
Atlanta, Georgia



Shop at the IMF Mall & Support the IMF

 

Breakthrough in MRD Detection Is Important Advance for Black Swan Research Initiative®

A two-day workshop cohosted by the IMF on March 21-22 in Salamanca, Spain will provide hands-on training to researchers and lab technicians from around the world on a new automated and highly sensitive flow cytometry method for detecting minimal residual disease (MRD) in multiple myeloma. According to IMF Chairman Dr. Brian Durie, the ability to measure MRD with extreme precision is a critical tool for the IMF's signature Black Swan Research Initiative® and offers "a much clearer framework for a cure." On March 24th, an FDA panel will consider if the method can be accepted as a new benchmark for MRD testing in myeloma. READ MORE

x
 

Clinical Trial for Newly Diagnosed Myeloma Patients x

A clinical trial is enrolling newly diagnosed myeloma patients at over 100 medical centers in North America and Europe. This is a Phase 3 clinical trial in which the investigational oral drug MLN9708 is being studied in multiple myeloma to determine whether MLN9708 – taken in combination with lenalidomide and dexamethasone – may potentially slow the disease growth. Patients will have a 50 percent chance to receive either MLN9708 in combination with lenalidomide plus dexamethasone or a placebo in combination with lenalidomide plus dexamethasone. To learn more about this study and how to participate, CLICK HERE.

x
 

Missouri Passes Oral Anticancer Law

On March 19th, Governor Jay Nixon of Missouri signed SB 668, the Cancer Treatment Fairness Act, into law, making Missouri the 29th state to pass oral anticancer treatment legislation. This law puts in place a cap of $75 per prescription per month for oral anticancer medications under private insurance plans. Thanks to the great work of our Missouri ACTION team, who delivered over 375 postcards to Governor Nixon requesting his signature on the bill, many more cancer patients in Missouri will have affordable access to all anticancer treatments. Catch up on what is happening in seven other states with As the Bill Turns: Episode 11.

x

 
Florida Support Group Promotes Myeloma Awareness Month on the Radio

Florida Panhandle Multiple Myeloma Support Group members are using their voices during Myeloma Awareness Month. Support group members Sarah Davis, Mike Davis, and Sheila Wilson were interviewed on the radio in Panama City, Florida by Powell Broadcasting's Tiffany "Flip Flop" Dunning about myeloma, treatment options, recent advances, and advocacy. The interview aired on Sunday, March 16th on four Florida radio stations, and the archive can be heard HERE.

x  
 
Join Our Mailing List
12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF Hotline: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe 
www.myeloma.org

 related articles